Skip to main content
logo
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
96.12
+2.83 (3.03%)
At close: Nov 4, 2026, 4:00 PM EST
96.48
+0.36 (0.37%)
Pre-market: Nov 5, 2026, 5:30 AM EST

KNSA Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Net Income
47.3525.4322.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33
Depreciation & Amortization
0.490.470.470.470.380.360.350.40.40.430.470.540.60.60.60.60.490.650.660.67
Loss (Gain) From Sale of Assets
0.010.02-0.05-0.05-0.04-0.030.01---0.02-0--0.180.01-0.010.03-0.1
Loss (Gain) From Sale of Investments
-0.340.091.3-0.930.6-0.840.260.82-0.49-0.190.3-0.31.44-1.15-1.06-0.2-0.120.080.160.05
Stock-Based Compensation
13.0711.6410.0610.2410.148.887.758.37.837.367.217.776.796.476.126.376.046.686.036.13
Other Operating Activities
-5.563.675.524.15.173.573.83-2.4-2.8911.415.14-24.9711-18.681.921.14-185.070.750.740.75
Change in Accounts Receivable
-7.29-0.27-7.6336.15-19.838.161.66-16.84-4.44-4.465.27-18.2321.61-17.2312.89-9.16-3.3521.63-25.46-0.69
Change in Inventory
-37.12.21-18.25-13.56.79-26.114.32.326.18-7.583.84-5.54-1.63-0.53-1.83-6.985.3-6.69-9.551.93
Change in Accounts Payable
-8.19-1222.27-4.12-2.736.930.06-6.280.911.73-2.667.230.36-0.74-6.516.43-1.05-0.861.520.25
Change in Unearned Revenue
-------20-0-0.16-0.29-2.18-2.24-1.986.66-14.2914.29-12-
Change in Other Net Operating Assets
45.1115.9213.937.3514.769.36-4.4221.342.950.552.4214.74-7.0914.52-10.960.041.45-10.12.278.26
Operating Cash Flow
47.5547.250.253.8933.6828.0922.3218.77-2.245.173.994.3316.99-3.74-4.27-11.5862.05-7.82-36.85-18.88
Operating Cash Flow Growth (YoY)
41.19%68.01%124.87%187.13%-443.54%459.92%333.99%-----72.63%-------

Investing Activities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Capital Expenditures
-0.18-0.66-0.16-0.63-0.67-0.17-0.1-0.19---0.08-0.06-0.02-0.03-0.020.03-0.02-0.12--0.25
Sale of Property, Plant & Equipment
---------0.03-----0.01-0.010.09--
Investment in Securities
-138.38-72.92-31.76-70.18-62.08-3.72-51.4465.49-6.35-46.8225.61-14.84-12.2635.57-37.9-42.719.0738.29-22.72-49.79
Investing Cash Flow
-138.56-73.58-31.92-70.81-62.76-3.88-51.5465.29-6.35-46.825.52-14.89-12.2835.53-37.92-42.6619.0438.27-22.72-50.04

Financing Activities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Issuance of Common Stock
6.0817.586.398.5816.2512.753.182.729.41.143.990.961.660.580.511.290.570.570.991.21
Repurchase of Common Stock
-9.08-5.47-0.32-0.92-4.35-2.05-0.41-0.58-2.71-1.31-0.38-0.26-1.11-0.42-0.42-0.1-0.21-0.02-0.57-
Financing Cash Flow
-312.116.077.6611.910.72.772.146.69-0.183.610.70.550.160.091.190.360.540.421.21

Net Cash Flow

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Net Cash Flow
-94.02-14.2824.36-9.26-17.1834.91-26.4586.21-1.9-41.8133.12-9.875.2631.95-42.1-53.0581.4530.98-59.15-67.71

Free Cash Flow

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
47.3746.5350.0453.2633.0127.9322.2318.58-2.245.173.94.2716.97-3.78-4.29-11.5462.03-7.94-36.85-19.14
Free Cash Flow Growth (YoY)
43.51%66.63%125.14%186.70%-440.34%469.43%335.16%-----72.64%-------
Free Cash Flow Margin
16.56%19.10%23.35%26.35%18.25%17.81%16.13%15.16%-1.99%4.76%4.89%5.12%25.31%-5.29%-8.88%-18.65%62.57%-29.43%-114.47%-102.08%
Free Cash Flow Per Share
0.560.560.610.650.410.360.290.26-0.030.070.060.060.24-0.05-0.06-0.160.88-0.12-0.53-0.28
Levered Free Cash Flow
29.2925.6132.9248.0519.5617.0413.240.58.652.7710.663.6612.490.16-2.52-10.0349.17-0.28-41.22-2.7
Unlevered Free Cash Flow
29.2925.6132.9248.0519.5617.0413.240.58.652.7710.663.6612.490.16-2.52-10.0349.17-0.28-41.22-2.69

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash Income Tax Paid
-0.01-0-03.011.26-1.51--0.23.523.26.081.323.29-0.42
Change in Working Capital
-7.465.8710.3225.88-1.02-1.671.620.545.6-9.918.58-3.9611.01-5.960.26-23.9516.633.97-19.229.75
SEC Filings: 10-K · 10-Q